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Induced pluripotent stem (iPS) cell technology demonstrates that somatic cells can be reprogrammed to a pluripotent state by 
over-expressing four reprogramming factors. This technology has created an interest in deriving iPS cells from domesticated 
animals such as pigs, sheep and cattle. Moloney murine leukemia retrovirus vectors have been widely used to generate and 
study mouse iPS cells. However, this retrovirus system infects only mouse and rat cells, which limits its use in establishing iPS 
cells from other mammals. In our study, we demonstrate a novel retrovirus strategy to efficiently generate porcine iPS cells 
from embryonic fibroblasts. We transfected four human reprogramming factors (Oct4, Sox2, Klf4 and Myc) into fibroblasts in 
one step by using a VSV-G envelope-coated pantropic retrovirus that was easily packaged by GP2-293 cells. We established 
six embryonic stem (ES)-like cell lines in human ES cell medium supplemented with bFGF. Colonies showed a similar mor-
phology to human ES cells with a high nuclei-cytoplasm ratio and phase-bright flat colonies. Porcine iPS cells could form em-
bryoid bodies in vitro and differentiate into the three germ layers in vivo by forming teratomas in immunodeficient mice. 
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Porcine induced pluripotent stem (iPS) cells have great po-
tential in genetically engineered porcine production, human 
disease modeling and tissue transplantation [1]. However, 
porcine embryonic stem (ES) cells that originate from the 
inner cell mass (ICM) fail to be established because of a 
lack of knowledge on pre-implantation development and 
culture conditions in vitro. Recently, numerous papers report 
that iPS cells can be directly established by ectopic expres-
sion of four reprogramming factors (Oct4, Sox2, Klf4 and 
Myc) in somatic cells from mice [2], humans [3], rats [4], 
monkeys [5] and Tibetan miniature pigs [6]. Also, iPS cells 
have been used for nuclear transfer [7], precise gene target-
ing [8] and disease modeling [9]. 
Among the reprogramming gene deliver strategies [10], 
the Moloney murine leukemia derived retrovirus (MMLV) 
vector pMXs is widely used to efficiently generate and 
study iPS cells [2,3,11,12]. This technique can efficiently 
introduce and integrate stable transgenes into the genome of 
any mitotic mammal cell type. The retrovirus can fall into 
several categories according to the viral envelop and recog-
nized cell type. Ecotropic virus recognizes a receptor found 
only on mouse and rat cells. Amphotropic virus recognizes 
a receptor on a broad range of mammalian cell types. Pan-
tropic virus coated by VSV-G protein infects mammal and 
non-mammal cells. VSV-G protein mediates viral entry via 
lipid binding and plasma membrane fusion. MMLV retro-
virus vectors in mouse and human iPS cells are transcrip-       
tionally silent, which suggests complete induced pluripotent 
reprogramming [3,11,12]. In addition, monitoring exoge-
nous gene expression can be easily performed by real-time 
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quantitative-PCR (RT-qPCR). 
However, ecotropic pMXs retrovirus produced in 
PLAT-E packaging cells for mouse iPS cell generation 
yields low transfection efficiencies in non-mouse cells [3], 
although this limitation may be overcome by introducing a 
Slc7a1 receptor. In the present study, we describe a novel 
method to easily deliver pMXs retroviral vectors in one step 
to efficiently generate iPS cells from porcine somatic cells. 
1  Materials and methods 
1.1  Fibroblast derivation and culture 
Porcine embryonic fibroblasts were derived from day 26–30 
embryos using a standard procedure, maintained in high-    
glucose Dulbecco’s Modified Eagle Medium (DMEM; Cat# 
11960, Gibco, Invitrogen, USA) supplemented with 10% 
Fetal Bovine Serum (FBS; Cat# 10099, Gibco, Invitrogen, 
USA) and 1% nonessential amino acids (NEAA, Cat# 
11140-050, Invitrogen, USA) and incubated at 37°C with 
5% CO2. SW3 porcine fibroblasts from black male embryo 
were used to derive iPS cells. One day prior to retrovirus in-
fection, passage 10 SW3 fibroblasts were plated at 0.1×106 
cells per well in six-well-plates. MEFs were derived from 
CF-1 mouse 13.5 days post coitum (d.p.c) embryos and cul-
tured in DMEM supplemented with 10% FBS, 1 mmol L−1 
L-glutamine (Cat# 2503-081, Invitrogen, USA) 1% NEAA , 
0.1 mmol L−1 β-mercaptoethanol (Cat# 21985023, Invitro-
gen, USA) and 1% penicillin/streptomycin (Cat# 15140122, 
Invitrogen, USA). Passage 4 MEFs (mouse embryo fibro-
blasts) were mitotically inactivated by 10 μg mL−1 mitomy-
cin C (Sigma, USA) for 2.5–3 h and then frozen in 10% 
dimethyl sulfoxide (DMSO; Cat# 2650, Sigma, USA) at 
6×106 cells per vial. For iPS and ES cell culture, a vial of 
inactivated MEFs was thawed and plated into four six-well 
plates or 10 cm dishes. All reagents for cell culture were 
purchased from Invitrogen, USA. 
1.2  Retrovirus production and porcine iPS generation 
Retrovirus vectors were purchased from Addgene (www. 
addgene.com), pMXs-hOct3/4 (Cat# 17217), pMXs-hSox2 
(Cat# 17218), pMXs-hKlf4 (Cat# 17219) and pMXs-hc- 
MYC (Cat# 17220). VSV-G coated retrovirus was produced 
in GP2-293 cells according to the manufacturer’s instruc-
tions (Clontech, Germany). Briefly, 12 µg pMXs-vector and 
6 μg pVSV-G were co-transfected into GP2-293 cells by 
Lipofectamine 2000 (Cat# 11668019, Invitrogen, USA) at a 
ratio of 1 μg:2.5 μL, which were passaged <24 h before 
transfection without antibiotics. After 8–12 h, the medium 
was replaced with fresh fibroblast medium. After 48–72 h, 
supernatant containing virus was collected, filtered through 
a 0.45 μm pore-size membrane and concentrated by ultra-
centrifugation at 100000×g (Beckman). Retrovirus was used 
to infect fibroblasts for 6–12 h in the presence of 4–8 μg 
mL−1 polybrene (Sigma). After recovery for 1–2 d, infected 
porcine fibroblasts were trypsinized and seeded at 4×105 
cells per 10 cm inactivated MEF-coated plate followed by 
changing to an ES cell culture condition on the second day. 
iPS cell derivation medium was based on human serum- 
free and mouse ES cell culture media. ES cell-like colo-
nies were passaged at day 15–20 post-infection in human 
ES cell medium and expanded in mouse ES:human ES cell 
(1:1, v/v) medium. Mouse ES cell medium was DMEM 
supplemented with 15% FBS (Cat# 16141079, Invitrogen, 
USA), 1 mmol L−1 L-glutamine, 1% NEAA, 0.1 mmol L−1 
β-mercaptoethanol and 1000 U mL−1 Leukemia inhibitory 
factor (LIF, Cat# ESG1107, Millipore, Germany). Human 
ES cell medium was DMEM/F-12 (DMEM: nutrient mix-
ture F-12= 1:1; Cat# 11330057, Invitrogen, USA) supple-
mented with 20% KnockOut Serum Replacement (KSR; Cat# 
10828028, Invitrogen, USA), 0.5 mmol L−1 L-glutamine, 1% 
NEAA, 0.1 mmol L−1 β-mercaptoethanol, and 4 ng mL−1 
basic Fibroblast Growth Factor (bFGF; Cat# 13256029, 
Invitrogen, USA). Retrovirus production and infection were 
performed in a Biosafety Level 2 (BL2) facility. 
1.3  RNA extraction and R-qPCR 
Porcine iPS cells were trypsinized and pelleted followed by 
washing with cold phosphate buffer solution (PBS, Cat# 
14190, Invitrogen, USA) and resuspended in Trizol (Invi-
trogen, USA). RNA was extracted using an RNeasy Mini 
Kit (Cat# 74106, Qiagen) according to the manufacturer’s 
instructions and reverse-transcribed using a High Capacity 
cDNA Kit (Cat# 4368814, Applied Biosystems, USA). Ge-
nomic DNA was digested by DNase I (Qiagen). RNA con-
centration was determined by Nanodrop2000 (Thermo 
Fisher, USA). RT q-PCR was performed using a SYBR 
green super mix (Applied Biosystems) and 7900 Q-PCR 
machine. Primers for pMXs-vectors were as follows (5′−3′): 
pMXs-1811s (GACGGCATCGCAGCTTGGATACAC) as 
the common forward primer, Exo-hOct4 (CCCCAGGG- 
CCCCATTTTGGTACC), Exo-hSox2 (GGCACCCCTGG- 
CATGGCTCTTGGCTC), Exo-hKlf4 (ACGATCGTGGC- 
CCCGGAAAAGGACC) and Exo-hMyc (CAACAACCG- 
AAAATGCACCAGCCCCAG). Primers for endogenous 
factors were Endo-pSox2 (AGGGAAATGGGAGGAGAG 
and GAGTGTGGATGGGATTGGTG) and Endo-pNanog 
(CAGTCAAGAAGCAGAAGA and GCTAAGGTTCAG- 
GATGTT). Housekeeping gene GAPDH primers were 
ACTCACTCTTCTACCTTTGATGCT and TGTTGCTGT- 
AGCCAAATTCA. 
1.4  Immunostaining 
iPS cells were fixed in 4% paraformaldehyde for 15 min 
and permeabilized with 0.1% Triton X-100 in PBS for 10 
min. Cells were then blocked with 6% bovine serum albu-
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min (BSA, Sigma) in PBS for 30 min followed by washing 
in 1% BSA in PBS for 5 min three times. Cells were incu-
bated in primary antibodies (1:200) in blocking solution 
overnight at 4°C. Primary antibodies were purchased from 
Chemicon, Millipore. After three washes, cells were incu-
bated with a secondary antibody (1:200) diluted in blocking 
solution for 30 min at room temperature. DNA was stained 
with 4′,6-diamidino-2-phenylindole (DAPI) at 300 nmol L−1 
for 2–3 min. 
1.5  Karyotype analysis 
Porcine fibroblasts and iPS cells were growth arrested in 
100 ng mL−1 colcemid (Karyomax, Cat# 10092, Invitrogen, 
USA) for 4 h. Cells were collected and treated with 0.075 
mol L−1 KCl for 30 min. After centrifugation at 1000 r 
min−1, for 10 min, cell pellets were fixed in 1:3 (glacial 
acetic acid:methanol) for 10 min three times. For metaphase 
analysis, fixed cells were dropped on cold slides, dried at 
70°C for 3 h, then digested in 0.01% trypsin at 37°C and 
stained with 10% Giemsa (Invitrogen, USA). 
1.6  Embryoid bodies formation assay 
Porcine iPS cells were trypsinized into a single cell suspen-
sion, seeded on low-adhesive 10 cm culture plates and cul-
tured in embryoid body forming medium consisting of 
DMEM/F12, 20% Knockout Serum Replacement, 1% 
pen/strep, 1% NEAA, 0.5% L-glutamine and 0.1 mmol L−1 
β-mercaptoethanol. Low-adhesive culture plates were 
placed on a shaker at 50 r min−1 in a CO2 incubator, which 
prevented iPS cells from attaching. The culture medium was 
replaced every day. 
1.7  Teratoma formation 
iPS cells (1×106) were subcutaneously injected into the dor-
sal flanks of SCID (severe combined immunodeficient) 
mice. After 6–8 weeks, teratomas were dissected and fixed 
in 10% formalin phosphate. Samples were embedded in 
paraffin and sections were hematoxylin & eosin stained. 
2  Results 
2.1  Retroviral reprogramming of porcine fibroblasts 
into ES-like colonies 
Porcine fibroblasts (SW3) were initially infected by eco-
tropic retrovirus packaged in Plat-E cells. pMXs-GFP as a 
positive control showed a low infection efficiency of 10%– 
20% GFP+ cells (Figure 1A). This result indicated that por-
cine fibroblasts do not express the ecotropic virus receptor, 
which is similar to human cells reported by Yamanaka et al. 
[2,3]. We then attempted to generate VSV-G coated pan-
tropic retrovirus produced in GP2-293 cells, which resulted 
in a higher infection efficiency of 80%−90% GFP+ cells 
(Figure 1A). The GP2-293 cell line is derived from HEK 
293 cells and stably expresses viral gap and pol genes, 
which produces infectious virus by co-transfection of 
pMXs-vector with pVSV-G [13]. 
A 100-fold concentrated retrovirus supernatant contain-
ing four human factors Oct4/Sox2/Klf4/Myc was used to 
infect passage 3–6 porcine embryonic fibroblasts (SW3). 
After 1–2 d recovery, SW3 cells were transferred onto mi-
tomycin C-inactivated mouse embryonic fibroblast (MEF) 
feeder cells followed by evaluation of various ES cell me-
dium types. ES-like colonies formed and were passaged at 
day 15–20 (Figure 1B).The derivation scheme is shown in 
Figure 1A. 
During and following reprogramming, we evaluated 
mouse and human ES cell culture conditions. On day 5–6 
after transfection, fibroblasts underwent significant mor-
phology transformation in both types of media, similar to 
that of human and mouse iPS cell inductions [2,3]. Compact 
flat ES cell-like colonies appeared by day 10–14, which was 
consistent with a previous report by Esteban et al. [6]. By 
day 18–20, only human ES cell culture condition could 
maintain the morphology of regular human ES-like colonies, 
whereas differentiated and necrotic cells populated the 
mouse ES cell culture condition. This result indicated that 
porcine iPS cell characteristics may resemble human ES 
cells. Colonies cultured under the human ES cell condition 
were mechanically passaged onto MEF-seeded 12-well 
plates. Surviving colonies retained the original cell mor-
phology and could be expanded further. Six healthy iPS cell 
lines were established. Approximately 200 colonies showed 
alkaline phosphatase positive per 40000 parental fibroblasts 
in a side-by-side experiment (data not shown), indicating a 
0.5% reprogramming efficiency. 
2.2  Porcine iPS cells share similar characteristics with 
human ES cells 
iPS cell lines maintained in human ES cell medium (20% 
knockout serum-replacement supplemented with 4 ng mL−1 
bFGF) rapidly proliferated, and exhibited a flat morphology, 
clear boundaries and a high nuclei to cytoplasm ratio, which 
are typical human ES cell characteristics. Porcine iPS cell 
lines were passaged every three days at a 10–15 split ratio 
using a method for human ES cell passage [14]. The method 
involves collagenase IV (Invitrogen, USA) treatment for 
10–15 min followed by mechanical passaging. All cell lines 
were subcultured beyond 20 passages and maintained a 
normal 38 XY karyotype compared with that of the original 
fibroblasts (Figure 2A). Long-term chromosomal stability in 
culture is essential for iPS cell use in producing transgenic 
animals. 
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Figure 1  Porcine iPS cell generation using a pantropic retroviral system. A, SW3 porcine fibroblasts infected by ecotropic retrovirus (upper) and pantropic 
retrovirus (lower), respectively. Images, 100×. B, Timelines for reprogramming by pantropic retrovirus transfection. C, Typical human ES cell-like colonies  
appeared by day 15 under human ES cell culture condition. Cells were visualized by a NIKON inverted microscope TS100, 100×. 
Induced porcine iPS cells expressed numerous common 
protein and cell surface carbohydrate antigens similar to that 
of human ES cells. Immunocytochemistry indicated strong 
ES cell marker expression including Oct4 and Sox2, and 
stem cell surface markers SSEA-3, SSEA-4 and Tra-1-60. 
However, the pluripotency marker Nanog was weakly de-
tected by immunostaining, which was consistent with 
RT-qPCR data (Figure 3B). 
2.3 Activation of endogenous pluripotent genes in por-
cine iPS cells 
We analyzed the gene expression of reprogramming factors 
by RT-qPCR and found significant decreases compared 
with that of porcine fibroblasts at two days post-infection, 
which corresponded to the highest human O/S/K/M trans-
gene expression level. These results showed that exogenous 
genes remained at a high level compared with previous re- 
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Figure 2  A, Representative images of passage 4 porcine iPS cell normal karyotypes (right) compared with that of original fibroblasts (left). Image, 600×. B, 
Immunostaining of porcine iPS cells for stem cell markers. Cells were visualized by a NIKON inverted fluorescence microscope Ti, 200×. 
 
Figure 3  A, Gene expression analysis of porcine iPS cells. RT-qPCR analysis of retrovirus vector expression relative to infected fibroblasts. Day 2 infected 
porcine fibroblasts (2dpipFibs) were used as a positive control, which expressed the highest level of reprogramming factors. pFibs, pig fibroblasts without 
virus infection were used as a negative control; HES3 cells show that the PCR primers were vector-specific. LP 2–6 P7 represent passage 7 porcine iPS cell 
lines. B, RT-qPCR analysis of endogenous pluripotency-related gene expression in passage 15 fibroblasts and iPS cells. HES3 cells show that the PCR prim- 
ers were porcine endogenous-specific. All data were presented as mean±SD. 
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ports [6,15]. Retrovirus silencing in mouse and human iPS 
cells is an important event [11], which indicates endogenous 
gene maintenance of pluripotency in fully reprogrammed 
iPS cells [12]. Thus, iPS cells generated by this system 
demonstrated partial reprogramming. Exogenous genes 
down-regulation can result in abnormal morphology and 
differentiation as reported by a previous porcine iPS cell 
study [16], which used doxycyline-induced lentivirus vec-
tors. In our novel pMXs retroviral system, maintained ex-
ogenous gene expression in iPS cells conferred “stemness” 
and could be analyzed by RT-qPCR to elucidate culture 
conditions that were specific to porcine cells. 
2.4  In vitro and in vivo differentiation of porcine iPS 
cells 
In vitro and in vivo differentiation potentials are the major 
characteristic of pluripotent stem cell lines [2]. To test 
whether porcine iPS cells could form embryoid bodies 
(EBs), we cultured porcine iPS cell lines in ES cell culture 
medium without bFGF on low-adhesive culture plates. All 
six iPS cell lines were able to form EBs in 4–6 d (Figure 
4A), indicating a capacity to differentiate in vitro. 
To examine whether iPS cells could differentiate into the 
three germ layers in vivo, we injected the sw3-hOSKM lp4 
iPS cell line into the dorsal flanks of SCID mice. After two 
months, tumors developed and contained various tissue types 
as determined by histological examination (Figure 4B) in-
cluding endoderm, mesoderm and ectoderm. 
3  Discussion 
Various methods for exogenous reprogramming factor de-
livery have been used to generate mouse and human iPS 
cells, which have been recently reviewed by Maherali et al. 
[10] and O’Malley et al. [17]. Retrovirus vectors [3], con- 
stitutive and dox-inducible lentivirus [18] can yield high 
gene expression and iPS cell derivation efficiencies. How- 
ever, these vectors also permanently integrate into the ge- 
 
 
Figure 4  In vitro and in vivo differentiation of porcine iPS cells. A, EB formation after 6 d suspension culture. B, Histological sections of tumors grown in 
SCID mince injected with the SW3-hOSKM LP4 cell lines. Differentiated tumors contain tissues derived from the three germ layers including cartilage  
(mesoderm), gut-like epithelia (ectoderm), muscle (endoderm) and glands (endoderm). Image, 400×. 
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nome causing genetic alteration that may affect iPS cell use 
in clinical applications. Thus, iPS cell production without 
genetic modification and complete pluripotency is ideal. 
Excisable piggyBac (PB) [19] and Cre-loxP [20] systems 
can delete exogenous genes after reprogramming to derive 
transgene-free iPS cells. Although, a second round of 
transposase expression in the PB system may alter the ge-
nome resulting in chromosomal abnormality. In addition, 
the validation of factor-excised clones is time-consuming. 
Adenovirus [21], transient transfection [20] and protein 
transduction [22] rarely cause genome alteration yielding 
“clean” iPS cells, which increases safety in the clinic. 
However, low reprogramming efficiencies limit their use in 
the derivation and study of iPS cells. Recently, synthetic 
modified mRNA [23] was shown to have high efficiency 
and safety in human iPS cell generation. 
The MMLV-based retrovirus used in this study was ini-
tially used to derive mouse and human iPS cells [2,3]. These 
retroviral vectors in iPS cells underwent auto-silencing and 
claimed a pluripotent state. This retrovirus type can be eas-
ily produced and yields high infection efficiencies. More-
over, retroviral vector expression can be easily analyzed by 
RT q-PCR. This strategy allowed us to screen high quality 
iPS cells with low or no reprogramming factor expression. 
Also, this method may be applied to other species such as 
cattle, sheep, dogs, cats and rats. 
iPS cell technology has created interest in genetic ma-
nipulation such as homologous recombination, gene knock-    
out and knock-in to select and expand positive cell colonies 
and improve the efficiency of nuclear transfer [7,24]. Por-
cine ES cells established thus far are not authentic pluripo-
tent stem cells as determined by the mouse ES cell standard 
of chimera production. There are numerous limitations to 
overcome before establishing reprogramming factor-inde-    
pendent iPS cells [16]. Other transcription factors may be 
required for porcine iPS cell induction because authentic ES 
cells have not been derived from the porcine ICM. Optimal 
culture conditions that maintain pluripotency and long-term 
porcine ES cell proliferation remain unknown [25]. Por-
cine-specific pluripotency and iPS cell selection markers are 
also unknown. iPS cells derived from somatic cells may 
delineate these unknown factors. 
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